Secondary Endpoints
The secondary endpoints were (1) changes in the scores of psychological symptoms and quality of life at wk 4 during the consumption period from the baseline in the YIT10347 and placebo groups; and (2) gastric emptying time measured by the 13C breath test in the 2 groups.